Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- CMS launches model to improve care coordination for children and families
- 3/27/2026 10:01:01 AM
- The American Medical Association (AMA) welcomed a newly announced care model from the Centers for Medicare & Medicaid Services (CMS) designed to help Medicaid families better navigate and coordinate their health care.
- Activating Your Brain While Sitting Helps Reduce Dementia Risk
- 3/26/2026 11:08:15 AM
- New research distinguishing between passive and mentally active sitting in association with dementia has found that adults who engaged in extended durations of mentally passive sedentary behaviors had a higher risk of dementia.
- AMA launches nutrition education initiative
- 3/25/2026 10:52:11 AM
- The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.
- Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
- 3/24/2026 1:40:24 PM
- • Approval in moderate-to-severe patients was based on pivotal study results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo • BP is a chronic, relapsing skin disease with underlying type 2 inflammation characterized by intense itch alongside painful blisters and other lesions • BP is the …
- Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
- 3/19/2026 12:40:05 PM
- The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of neurological manifestations of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder.
- FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
- 3/19/2026 9:18:14 AM
- Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE offers an innovative new option for patients with moderate-to-severe plaque psoriasis to address patients cycling on topical therapies in need of systemic treatment Johnson & Johnson (NYSE: JNJ) …
- Elsevier expands article submission screening tool to strengthen research credibility
- 3/19/2026 8:50:11 AM
- Elsevier has expanded its Check Integrity screening tool across nearly 2,000 of its journals to help identify potential ethical issues in research papers before publication, following a successful pilot phase.
- Middle East regional conflict blocking lifesaving aid for over 400,000 children
- 3/19/2026 8:48:22 AM
- The conflict in the Middle East and wider region is obstructing key delivery routes for humanitarian supplies, delaying lifesaving medical shipments for at least 410,000 children in three countries, said Save the Children, warning the global impact will only grow.1 The escalating conflict is having dire ripple effects on global aid supplies due to disruptions to key …
- Future Family Partners with Kindbody to Expand Access to Fertility Care Through Innovative Financing Solutions
- 3/18/2026 8:00:00 AM
- Future Family, the only financing platform built exclusively for fertility patients, today announced a partnership with Kindbody, a leading fertility and family-building benefits provider and fertility care delivery platform.
- L’Oréal and Nvidia to accelerate beauty discovery powered by predictive AI science
- 3/18/2026 3:17:45 AM
- L’Oréal announced the expansion of its AI partnership with NVIDIA, aimed at accelerating and re-defining beauty innovation through AI-driven computational chemistry.
- Recent Open Access Research on Telemedicine Adoption, AI in Healthcare, Digital Health Innovation, and Cybersecurity
- 3/17/2026 8:00:00 AM
- The current issue of Telehealth and Medicine Today ( THMT ) highlights how telemedicine, artificial intelligence, and digital health technologies are moving from experimentation to real world implementation across healthcare systems globally.
- MedPAC to Congress: Increase Medicare payments
- 3/16/2026 11:32:41 AM
- The Medicare Payment Advisory Commission (MedPAC) recommended (PDF) that Congress increase the payment update for physicians caring for Medicare patients in 2027, reinforcing the urgent need to stabilize Medicare physician payment and protect patient access to care.
- Advancing Decentralized Health, AI, and Trust Driven Innovation
- 3/16/2026 8:00:00 AM
- Blockchain in Healthcare Today (BHTY), the leading peer reviewed platforms journal at the intersection of blockchain, artificial intelligence, and decentralized health systems, current issue is focused on evidence, governance, and real world implementation of next generation healthcare technologies.
- Professor Martin Curley Appointed Co-Editor-in-Chief of Telehealth and Medicine Today
- 3/16/2026 8:00:00 AM
- Telehealth and Medicine Today (THMT), a leading international open access peer reviewed journal advancing research and innovation in telehealth, telemedicine, and digital health, is proud to announce the appointment of Professor Martin Curley as Co-Editor-in-Chief.
- Federal Audit Findings Prompt Call for NIH-Wide Scientific Integrity Standards
- 3/16/2026 7:00:00 AM
- The Patient Centered Care Advocacy Group today submitted to National Institutes of Health Director Dr. Jay Bhattacharya “Strengthening NIH Research Standards: A Framework for Scientific Integrity, Transparency and Stakeholder Engagement,” a comprehensive proposal that advances his “replication revolution” vision by establishing systematic patient and stakeholder engagement in …
- Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate‑risk non–muscle-invasive bladder cancer
- 3/14/2026 1:51:46 PM
- · Data presented at EAU 2026 show an 89 percent complete response rate in intermediate-risk disease with durable responses observed over 18 months and tolerable safety profile · Erda-iDRS has the potential to be the first targeted treatment for early-stage bladder cancer Johnson & Johnson (NYSE:JNJ) announced results from an open-label, multicenter Phase 1 study …
- Managing blood pressure may change breast cancer outlook
- 3/13/2026 11:48:08 PM
- A new Kaiser Permanente study suggests that managing high blood pressure may help women with advanced breast cancer live longer. The study found that women who took more than one type of blood pressure drug were much less likely to die than those taking just one type.
- “Seen At Last” by Dr. Debra Muth - Expose Hidden Misdiagnoses, Reclaim Your Health - Download Free on Amazon – 3 More Days (Until end of 03/13/2026)
- 3/11/2026 6:00:00 AM
- Best Seller Publishing is proud to announce the release of “Seen At Last: Uncovering Women’s Misdiagnoses & Reclaiming Health” by nationally recognized women’s health expert Dr.
- WHO launches first-ever implementation handbook to accelerate country action on hepatitis elimination
- 3/10/2026 4:59:40 PM
- The World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis B and C, to support countries to expand prevention, testing, treatment, service delivery and programme monitoring, through a comprehensive public health approach.
- Survey shows need to rebuild trust in evidence-based health information
- 3/6/2026 10:23:22 AM
- New survey findings from the Annenberg Public Policy Center highlight a widening trust gap in the nation’s health information landscape and underscore the importance of trusted medical voices grounded in science.